--- title: Clinical OMICs interview with David Atkins CEO Congenica description: Clinical OMICs features an interview with Congenica CEO David Atkins who talks about the genomic medicine landscape and Congenica's plans for the future. image: https://blog.congenica.com/hubfs/CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png --- - [Our Customers and Partners](http://www.congenica.com/our-customers) - [Our Product Portfolio](http://www.congenica.com/congenica-products) - **Inherited Diseases** - [Rare Disease](http://www.congenica.com/congenica-rare-disease) - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer) - [Prenatal Health](http://www.congenica.com/congenica-prenatal) - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening) - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro) - **Somatic Oncology** - [Solid Tumours](http://www.congenica.com/congenica-oncology) - **Pathogen** - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance) - [Our Services](http://www.congenica.com/congenica-services) - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services) - [Professional Services](http://www.congenica.com/professional-services) - [Customer Support](http://www.congenica.com/customer-support) - [Pharma Services](http://www.congenica.com/pharma-services) - Resources - [Publications](http://www.congenica.com/publications) - [Supporting materials](http://www.congenica.com/resources) - [News](https://blog.congenica.com/) - [Events and webinars](http://www.congenica.com/events-webinars) - [About us](http://www.congenica.com) - [Leadership Team](http://www.congenica.com/leadership) - [Quality](http://www.congenica.com/quality) - [Investors](http://www.congenica.com/investors) - [People and Vacancies](http://www.congenica.com/people) - [Contact us](http://www.congenica.com/contact) Login ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) [Overview](https://blog.congenica.com) [Clinical OMICs interview with David Atkins CEO Congenica](https://blog.congenica.com/clinical-omics-interview-with-david-atkins-ceo-congenica) ![Clinical OMICs interview with David Atkins CEO Congenica](https://blog.congenica.com/hubfs/CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png) News Investor # Clinical OMICs interview with David Atkins CEO Congenica 6/25/2021    |    0 min read ## The May / June 2021 issue of Clinical OMICs features a four-page interview with Congenica CEO David Atkins, who talks about the genomic medicine landscape and Congenica's plans for the future. ![CEO David Atkins is inteviewed for Clinical OMICs](https://blog.congenica.com/hs-fs/hubfs/CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png?width=1200&name=CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png) In this in-depth article, Chris Anderson, Editor in Chief at Clinical OMICs, speak to David about:   - Significant developments at Congenica and lessons learned - The growth and outsourcing of sequencing capabilities - What Congenica's $50 million financing round means for the business  - New developments from Congenica, including  cancer offering  - New partnership with Sanford Health - Integrating genomic data into mainstream healthcare   To read the article in full, please visit [ClinicalOMICS](https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Flsc-pagepro.mydigitalpublication.com%2Fpublication%2F%3Fm%3D60453%26i%3D710667%26p%3D42%26ver%3Dhtml5%2C&data=04%7C01%7Crebecca.lamont%40congenica.com%7Cf54afb9c0cfb4781974008d937bfc901%7C73c2c2dab9a44b98a369170f486d894d%7C0%7C0%7C637602119123186143%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=O%2BeockynwK5hpAnK4rGW26NiJ5dpA1tqkwMtc8MVpI0%3D&reserved=0)   [![Read the article in full ](https://no-cache.hubspot.com/cta/default/6863388/942ed74a-deb7-4dd7-ae72-9d13b346e074.png)](https://cta-redirect.hubspot.com/cta/redirect/6863388/942ed74a-deb7-4dd7-ae72-9d13b346e074)   --- ### Related articles ![SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/hs-fs/hubfs/New%20logos/Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png?width=320&height=192&name=Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png) 9/2/2025 #### [SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/seqone-acquires-congenica-to-create-a-global-leader-in-ai-powered-genomic-medicine) Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries ![Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/hs-fs/hubfs/male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg?width=320&height=192&name=male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg) 11/6/2024 #### [Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/congenica-showcased-in-recently-launched-genomics-spotlight-2024-report) We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT). ![Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/hs-fs/hubfs/Onco%20.png?width=320&height=192&name=Onco%20.png) 6/19/2024 #### [Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/congenica-named-best-genomic-data-analysis-software-company-2024-by-ghp) We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine.  ##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory. - [Privacy Policy](http://www.congenica.com/privacy-policy) - [Cookie Policy](http://www.congenica.com/cookie-policy) Log in to Congenica ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) ![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png) Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.